Bone & Joint Infections (BJI) 2026
About the conference
The ASID Bone and Joint Infections Conference is the leading specialty event bringing together close to 300 delegates across orthopaedic surgeons, infectious disease physicians, clinical microbiologists, pharmacists, trainees and nurses as well as other professionals across allied health services, clinical trials and primary scientists. Over two days, we collaborate, and advance discuss across the latest developments in the prevention, diagnosis and management of bone and joint infections.
Why attend?
BJI 2026 brings together clinicians across multiple disciplines to advance the diagnosis, treatment and prevention of bone and joint infections. The meeting is designed to strengthen shared understanding, highlight differing clinical perspectives and provide practical, evidence-based strategies for managing complex musculoskeletal infections.
Delegates will engage with up-to-date research, expert discussions and real-world case insights—offering knowledge that can be directly applied to improving patient care.
Welcome note from ASID
On behalf of the Australasian Society for Infectious Diseases (ASID), we are delighted to invite you to participate in the 2026 ASID Bone and Joint Infections Conference. This leading meeting is held every two years and provides an excellent opportunity to focus on a multi-discipline collaboration to better the lives of many.
We look forward to welcoming you to Melbourne for this exciting meeting.
Professor Joseph Doyle Dr Irene Kourtis
President, ASID CEO, ASID
INTERNATIONAL KEYNOTE SPEAKERS
Dr Marjan Wouthuyzen-Bakker, University Medical Center Groningen
Marjan Wouthuyzen-Bakker is an infectious disease specialist working at the University Medical Center Groningen, the Netherlands. Her research field involves implant related infections; in particular periprosthetic joint infections and vascular graft infections. She is the past-president of the ESCMID study group of implant associated infections (ESGIAI) and the current vice-president of the European Bone and Joint Infection Society (EBJIS). She has a leading role in many PJI networks, like the Northern Infection Network on Joint Arthroplasty (NINJA) and the Orthopaedics Device Infection Network (ODIN).
Dr. Carlos Higuera-Rueda, Cleveland Clinic Florida
Dr. Carlos Higuera-Rueda, is currently a staff surgeon at the Cleveland Clinic Florida, where he divides his time between leadership, research, and patient care. He is the Director of the Levitetz Department of Orthopaedic Surgery and Director of Research of the Integrated Surgical Institute at Cleveland Clinic Florida. He currently holds the Amy and David Krohn Family Distinguish Chair in Orthopaedic Outcomes. Dr. Higuera completed his residency at the Cleveland Clinic and a clinical fellowship at Thomas Jefferson University Hospital
AUSTRALASIAN SOCIETY FOR INFECTIOUS DISEASESABN 20 108 151 093
ACN 155 632 698
PO BOX Q379 QVB SYDNEY 1230
Email: events@asid.net.au |
ASID acknowledges the Aboriginal and Torres Strait Islander peoples as Traditional Owners, Custodians and First Nations of Australia, and Māori as tangata whenua and Treaty of Waitangi partners in Aotearoa New Zealand.